Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02731066 · ClinicalTrials.gov registry record · NA

Substrate Utilization, Exercise Performance, and Skeletal Muscle Response to Energy Deficit and Altitude Acclimatization

A NA study, sponsored by United States Army Research Institute of Environmental Medicine.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT02731066 is a NA study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02731066, a NA study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

This research will evaluate nutrition requirements for missions at high altitude (i.e. \>7800 feet above sea level) and the information obtained can be used to optimize nutrient content specifications for combat rations. The objectives are: 1. Determine whether loss of lean body mass resulting from negative calorie balance over a 22-d period at high altitude can be prevented by increasing dietary protein intake. 2. Determine the efficacy of carbohydrate (glucose and fructose) supplementation on aerobic exercise performance at sea level, acute exposure to high altitude, and in response to 22-d period of negative calorie balance at high altitude. 3. Determine cognitive function, sleep patterns, and behavioral responses to high altitude and underfeeding. 4. Determine appetite and eating behavior in response to high altitude and sustained underfeeding. 5. Examine the effects of high altitude, negative calorie balance, dietary intake manipulations on gut health.

Interventions

  • OTHER Standard pro
  • OTHER High pro
  • OTHER carbo bev
  • OTHER placebo bev

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2016-03
Est. Completion 2016-09
Phase NA

What the Registry Record Tells You About NCT02731066

The ClinicalTrials.gov registry entry for NCT02731066 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Standard pro is the first listed.

NCT02731066 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02731066 about?

NCT02731066 is a clinical study titled "Substrate Utilization, Exercise Performance, and Skeletal Muscle Response to Energy Deficit and Altitude Acclimatization". This research will evaluate nutrition requirements for missions at high altitude (i.e. \>7800 feet above sea level) and the information obtained can be used to optimize nutrient content specifications for combat rations. The objectives are: 1. Determine whether loss of lean body mass resulting fro...

What is the current status of trial NCT02731066?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2016-03. Estimated completion is 2016-09.

What interventions are being tested in trial NCT02731066?

The interventions under investigation include: Standard pro (OTHER), High pro (OTHER), carbo bev (OTHER), placebo bev (OTHER).

Who is sponsoring clinical trial NCT02731066?

This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.